If the data is found satisfactory, an approval for Covishield, Oxford-AstraZeneca's vaccine candidate, can come in by the first week of January
from Latest News https://ift.tt/3gNplKt
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd
Home
Business
Business News
Business Standard
Latest News
Serum likely to submit final Covid-19 vaccine trial data in 10 days
Tuesday, December 15, 2020
Related Posts:
Lakshmi Vilas Bank may decide on proposed merger with Clix on SaturdayOn September 29, Business Standard had reported that Clix Capital woul… Read More
Coronavirus LIVE: India cases past 8.4 mn; US sees 100000+ fresh casesCoronavirus update: Maharashtra has 1,703,444 coronavirus cases, Karna… Read More
No big releases in 2020 as uncertainty remains over cinema hall attendanceMost blockbusters have been pushed to 2021 from Latest News https://i… Read More
Manipal Hospitals looks for expansion with Columbia Asia acquisitionThe acquisition of Columbia Asia will expand the privately-held chain'… Read More
0 comments: